R. A. Gatenby, A. S. Silva, R. J. Gillies, B. R. Frieden: Adaptive therapy. In: Cancer Res. 69. Jahrgang, Nr.11, Juni 2009, S.4894–4903, doi:10.1158/0008-5472.CAN-08-3658, PMID 19487300.
Paolo Boffetta, John M. Kaldor: Secondary Malignancies Following Cancer Chemotherapy. In: Acta Oncologica. 33. Jahrgang, Nr.6, 1994, S.591–598, doi:10.3109/02841869409121767.
L. M. Morton, G. M. Dores, M. A. Tucker, C. J. Kim, K. Onel, E. S. Gilbert, J. F. Fraumeni Jr., R. E. Curtis: Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975–2008. In: Blood. 2013; doi:10.1182/blood-2012-08-448068.
H. Ludwig, S. van Belle, P. Barrett-Lee et al.: The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. In: Eur. J. Cancer. 40. Jahrgang, Nr.15, Oktober 2004, S.2293–2306, doi:10.1016/j.ejca.2004.06.019, PMID 15454256.
Lise Estcourt, Simon Stanworth, Carolyn Doree, Sally Hopewell, Michael F Murphy: Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. In: Cochrane Database of Systematic Reviews. 16. Mai 2012, doi:10.1002/14651858.CD004269.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
Lise J Estcourt, Simon J Stanworth, Carolyn Doree, Sally Hopewell, Marialena Trivella: Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. In: Cochrane Database of Systematic Reviews. 18. November 2015, doi:10.1002/14651858.CD010983.pub2 (wiley.com [abgerufen am 9. Juli 2020]).
Bettina Berger: Fasten bei Tumorerkrankungen – ist das ratsam? In: Deutsche Zeitschrift für Onkologie. Band54, Nr.1, März 2022, S.14–17, doi:10.1055/a-1746-6286.
Stefanie de Groot et al.: Effects of short-term fasting on cancer treatment. In: Journal of experimental & clinical cancer research: CR. Band38, Nr.1, 22. Mai 2019, S.209, doi:10.1186/s13046-019-1189-9, PMID 31113478, PMC 6530042 (freier Volltext) – (englisch).
Francesco Plotti et al.: Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment. In: Chemotherapy. Band65, Nr.3-4, 2020, S.77–84, doi:10.1159/000510839, PMID 33197913 (englisch).
Federico Bozzetti: Calorie restriction in cancer patients undergoing chemotherapy: Facts, phantasy or misunderstanding. In: Clinical Nutrition (Edinburgh, Scotland). Band41, Nr.6, Juni 2022, S.1316–1319, doi:10.1016/j.clnu.2022.04.020, PMID 35552051 (englisch).
duden.de
Chemo. In: duden.de. Abgerufen am 21. August 2015.
H. H. Skipper: Perspectives In Cancer Chemotherapy: Therapeutic Design. In: Cancer Res. 24. Jahrgang, September 1964, S.1295–1302, PMID 14221786.
J. H. Goldie, A. J. Coldman: A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. In: Cancer Treat Rep. 63. Jahrgang, Nr.11–12, 1979, S.1727–1733, PMID 526911.
R. A. Gatenby, A. S. Silva, R. J. Gillies, B. R. Frieden: Adaptive therapy. In: Cancer Res. 69. Jahrgang, Nr.11, Juni 2009, S.4894–4903, doi:10.1158/0008-5472.CAN-08-3658, PMID 19487300.
R. S. Mehta, R. Bornstein, I. R. Yu, R. J. Parker, C. E. McLaren, K. P. Nguyen, K. T. Li, J. P. Fruehauf: Breast cancer survival and in vitro tumor response in the extreme drug resistance assay. In: Breast Cancer Research and Treatment. Band 66, Nummer 3, April 2001, ISSN0167-6806, S. 225–237, PMID 11510694.
R. K. Gibb u. a.: Apoptosis as a Measure of Chemosensitivity to Cisplatin and Taxol Therapy in Ovarian Cancer Cell Lines. In: Gynecol Oncol 65, 1997, S. 13–22. PMID 9103385
J. A. Houghton und P. J. Houghton: Cellular responses to antimetabolite anticancer agents: cytostasis versus cytotoxicity. In: Prog Cell Cycle Res 2, 1996, S. 175–185. PMID 9552394
H. Ludwig, S. van Belle, P. Barrett-Lee et al.: The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. In: Eur. J. Cancer. 40. Jahrgang, Nr.15, Oktober 2004, S.2293–2306, doi:10.1016/j.ejca.2004.06.019, PMID 15454256.
Stefanie de Groot et al.: Effects of short-term fasting on cancer treatment. In: Journal of experimental & clinical cancer research: CR. Band38, Nr.1, 22. Mai 2019, S.209, doi:10.1186/s13046-019-1189-9, PMID 31113478, PMC 6530042 (freier Volltext) – (englisch).
Francesco Plotti et al.: Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment. In: Chemotherapy. Band65, Nr.3-4, 2020, S.77–84, doi:10.1159/000510839, PMID 33197913 (englisch).
How Far Are We from Prescribing Fasting as Anticancer Medicine? published 01.12.2020, PMID 33271979, abgerufen am 22. Dezember 2022.
Federico Bozzetti: Calorie restriction in cancer patients undergoing chemotherapy: Facts, phantasy or misunderstanding. In: Clinical Nutrition (Edinburgh, Scotland). Band41, Nr.6, Juni 2022, S.1316–1319, doi:10.1016/j.clnu.2022.04.020, PMID 35552051 (englisch).
G. Morgan, R. Ward, M. Barton: The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. In: Clin Oncol (R Coll Radiol)., 2004 Dec, 16(8), S. 549–560. PMID 15630849
L. Mileshkin, D. Rischin, H. M. Prince, J. Zalcberg: The contribution of cytotoxic chemotherapy to the management of cancer. In: Clin Oncol (R Coll Radiol). Band 17, Nr. 4, Juni 2005, S. 294. PMID 15997929
Lise Estcourt, Simon Stanworth, Carolyn Doree, Sally Hopewell, Michael F Murphy: Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. In: Cochrane Database of Systematic Reviews. 16. Mai 2012, doi:10.1002/14651858.CD004269.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
Lise J Estcourt, Simon J Stanworth, Carolyn Doree, Sally Hopewell, Marialena Trivella: Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. In: Cochrane Database of Systematic Reviews. 18. November 2015, doi:10.1002/14651858.CD010983.pub2 (wiley.com [abgerufen am 9. Juli 2020]).
zdb-katalog.de
R. S. Mehta, R. Bornstein, I. R. Yu, R. J. Parker, C. E. McLaren, K. P. Nguyen, K. T. Li, J. P. Fruehauf: Breast cancer survival and in vitro tumor response in the extreme drug resistance assay. In: Breast Cancer Research and Treatment. Band 66, Nummer 3, April 2001, ISSN0167-6806, S. 225–237, PMID 11510694.